1. Mooser V, Nussberger J, Juillerat L, et al.: Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990, 15: 276–282.
2. Ihara M, Urata H, Kinoshita A, et al.: Increased chymase-dependent production of angiotensin-II in human atherosclerotic aorta. Hypertension 1999, 33: 1399–1405.
3. Murakami M, Matsuda H, Kubota E, et al.: Role of angiotensin-II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney International 1997, 63: S132–S135.
4. Hollenberg NK, Fisher NDL, Price DA:Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system. Hypertension 1998, 32: 387–392.
5. McConnaughey MM, McConnaughey JS, Ingenito AJ:Practical considerations of the pharmacology of angiotensin receptor blockers. J Clin Pharmacol 1999, 39: 547–559.